skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies

Journal Article · · Laryngoscope; (USA)
; ; ;  [1]
  1. Medical College of Wisconsin, Milwaukee (USA)

Fluosol-DA 20%, a synthetic perfluorocarbon emulsion first developed as a blood substitute, is currently being investigated as a radiation sensitizer. Theoretically, an oxygen-carrying perfluorocarbon emulsion combined with oxygen inhalation might be able to increase tumor response by decreasing the relative proportion of hypoxic tumor cells. Twenty-one patients with advanced head and neck malignancies receiving primary radiation therapy were evaluated for treatment-related toxicity. Mucosal reactions and weight loss during treatment in the group of patients who received the perfluorocarbon emulsion and the group who did not were comparable. Late sequelae appeared comparable. No patient in either group who completed radiation therapy required an interruption of the treatment course. We conclude that Fluosol-DA 20% is a tolerated adjunct to primary radiation therapy. Further study is needed to determine whether the agent will improve local/regional tumor control.

OSTI ID:
6919701
Journal Information:
Laryngoscope; (USA), Vol. 100:3; ISSN 0023-852X
Country of Publication:
United States
Language:
English

Similar Records

Clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck
Journal Article · Fri Aug 01 00:00:00 EDT 1986 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6919701

Lack of complications in long-term survivors after treatment with Fluosol[sup R] and oxygen as an adjuvant to radiation therapy for high-grade brain tumors
Journal Article · Thu Jul 15 00:00:00 EDT 1993 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:6919701

Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma
Journal Article · Thu Jan 01 00:00:00 EST 1987 · Biomater., Med. Devices, Artif. Organs; (United States) · OSTI ID:6919701